Both decreased and increased apoptosis can lead to pathological changes
December 17, 2025: Federal Litigation Created for People Who Lost Their Vision After Taking Ozempic On December 15, 2025, the Joint Panel on Multidistrict Litigation (JPML) approved a request to consolidate lawsuits filed by people who experienced vision loss after taking Ozempic and other GLP-1 drugs
Key Takeaways GLP-1 receptor agonists (GLP-1RAs) are a critical advancement in managing type 2 diabetes and obesity, offering significant benefits in blood sugar control and weight loss, but differ in their mechanisms of action, dosing schedules, and side effects
Diabetic retinopathy worsening: Rapid blood sugar improvement can paradoxically worsen existing retinopathy
Zinc supports metallothionein and antioxidant defenses
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test reveals predispositions in peptide-pathway variants including those affecting growth hormone signaling and metabolic regulation